Cobas¿ infinity central lab IT solution Material Number: 07154003001 Calculator/Data Proces...

FDA Device Recall #Z-1368-2019 — Class II — February 4, 2019

Recall Summary

Recall Number Z-1368-2019
Classification Class II — Moderate risk
Date Initiated February 4, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Roche Diagnostics Corporation
Location Indianapolis, IN
Product Type Devices
Quantity 15 units

Product Description

Cobas¿ infinity central lab IT solution Material Number: 07154003001 Calculator/Data Processing Module, For Clinical Use

Reason for Recall

Using the following versions of cobas infinity software (2.0 thorough 2.5), there is a potential where the results from the first sample subsequent to the bottle change, (when using the Standby bottle function), does not display a quality control (QC) alarm when one should be present. If the QC is out of range on the stand-by bottle and it is not removed from the system, there is a potential that when the status of the Standby bottle changes from the Standby bottle to the Current bottle status, QC alarms will not be displayed next to the sample result.

Distribution Pattern

US Distribution to states of: AL, AZ, CA, GA, IA, MO, NJ, NY, SC, TN and TX.

Lot / Code Information

Software versions 2.0 thorough 2.5 Serial Numbers: 81191 81371 81385 81465 81469 81470 81481 81485 81527 81528 81618 81628 81652 81655 81662

Other Recalls from Roche Diagnostics Corporation

Recall # Classification Product Date
Z-1979-2019 Class II The Tina-quant lgA Gen.2 is an immunoturbidimet... Jun 3, 2019
Z-1928-2019 Class III cobas p 701 post-analytical units, Part Number ... Apr 4, 2019
Z-1927-2019 Class III cobas p 501 post-analytical units, Part Number ... Apr 4, 2019
Z-1194-2019 Class II Albumin BCP Product Usage: ALBP is an in v... Mar 18, 2019
Z-1249-2019 Class II cobas e 801 immunoassay analyzer Mar 15, 2019

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.